GluBio Therapeutics
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
San Diego, California, United StatesWebsite
www.glubiotx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About GluBio Therapeutics
杭州格博生物医药有限公司 is a biopharmaceutical company focused on the research and development of novel molecular glue degraders. Established in March 2021, it has research centers in Shanghai and San Diego, California. The company aims to address unmet clinical needs in areas such as oncology, autoimmune diseases, and genetic disorders through its proprietary molecular glue discovery platform. Currently, it has initiated clinical trials for two products in both China and the United States, with several more candidates in preclinical research.Explore more
GluBio Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GluBio Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on GluBio Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once GluBio Therapeutics has new funding data
Check if GluBio Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if GluBio Therapeutics is spiking on competitors!
Click to see if GluBio Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at GluBio Therapeutics
GluBio Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when GluBio Therapeutics launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to GluBio Therapeutics
Compare insights from companies similar to GluBio Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
GluBio Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
GluBio Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about GluBio Therapeutics.
GluBio Therapeutics financials insights
Gather financial insights about GluBio Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series A
$22M
GluBio Therapeutics Tech Stack
A closer look at the technologies used by GluBio Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GluBio Therapeutics
Sign Up For FreeTo access detailed company insights
杭州格博生物医药有限公司 is a biopharmaceutical company focused on the research and development of novel molecular glue degraders. Established in March 2021, it has research centers in Shanghai and San Diego, California. The company aims to address unmet clinical needs in areas such as oncology, autoimmune diseases, and genetic disorders through its proprietar... Read More
